Calcium Gen.2 (CA2) 의 안전성 경고

Department of Health에 따르면, 해당 안전성 경고 는 Hong Kong 에서 Roche 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

안전성 경고는 의료기기 제품과 관련된 중요한 정보와 권고사항을 담고 있습니다. 물론 안전성 경고가 배포되었다고 해서 해당 제품이 무조건 안전하지 않은 제품이라는 것은 아닙니다. 보건의료업계 종사자와 의료기기 사용자들에게 배포되는 안전성 경고에는 회수(recall)도 포함될 수 있습니다. 제조사가 안전성 경고를 작성하기도 하지만, 보건당국에서 작성하는 경우도 있습니다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Safety alert
  • 날짜
    2014-05-02
  • 사례 출판 날짜
    2014-05-02
  • 사례 국가
  • 사례 출처
    DH
  • 사례 출처 URL
  • 비고 / 경고
    Hong Kong data is current through September 2018. All of the data comes from the Department of Health (Hong Kong), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Hong Kong.
  • 데이터 추가 비고
    Medical Device Safety Alert
  • 원인
    Medical device safety alert: roche calcium gen.2 (ca2) medical device manufacturer, roche, has issued a field safety notice concerning calcium gen.2 (ca2). the affected catalogue numbers are 05061431190, 05061458190, 05061466190 and 05061474190. according to the manufacturer’s global complaint record, they received some customers complained of: duplicate and sens alarms during calibration, drop in quality control (qc) results , poor intermediate coefficient of variations (cv) for the ca2 (nm-bapta method) on the modular analytics analyzers. however, ca (gen.1) may seem to perform adequately. according to the manufacturer, it is assumed that the mentioned precision issue is due to the sensitivity of the ca2 assay to the maintenance condition of the modular analytics . on an analyzer maintained according to the manufacturer’s recommendations, the precision of ca2 should be within specifications. the manufacturer will implement a special hardware checking protocol to make sure the hardware condition of the system is satisfactory in the next preventative maintenance. furthermore, the manufacturer advises users to review their ca2 assay performance to see if they are affected by the mentioned symptoms. if users suspect that they are affected by the mentioned issue, the manufacturer advises them to perform a within run imprecision study (n=21) using qc materials for troubleshooting. the cv of the imprecision study should below 2%. then, users should contact the roche application representative with relevant data. according to the local supplier, the affected products were distributed in hong kong. if you are in possession of the affected product, please contact your supplier for necessary actions. posted on 2 may 2014.

Device

  • 모델명 / 제조번호(시리얼번호)
  • 제품 설명
    Medical Device Safety Alert: Roche Calcium Gen.2 (CA2)
  • Manufacturer

Manufacturer